Working… Menu

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04418141
Recruitment Status : Recruiting
First Posted : June 5, 2020
Last Update Posted : July 28, 2020
Novotech (Australia) Pty Limited
Information provided by (Responsible Party):
Curon Biopharmaceutical (Australia) Co Pty Ltd

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : April 2022